A Story of Renewed Possibilities JHs outcome demonstrates the potential of GLP-1 conservative therapy as part of a personalized lipedema treatment plan
None of this replaces peer-reviewed literature
J Cell Physiol 238(8):16411650 Lin CH et al (2024) Protein lipoylation: mitochondria, cuproptosis, and beyond
A 2024 debate paper on GLP-1 drugs in older patients, including those with kidney disease, points out that limited trial data and multiple medications make it harder to judge safety and effectiveness for frailer seniors
Due to its unique production process and the sole usage of the plant species of Pinus pinaster Ait
We know exactly how much weight people lose, how quickly, at what doses, with what side effects, and with what consistency